Concepedia

Lauren B. Ostermann

LB

8

Publications

212

Citations

8

H-Index

2021

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

University Hospital of Zurich

University of Zurich

Lauren B. Ostermann is an author at The University of Texas MD Anderson Cancer Center specializing in cell biology, medicine, and tumor biology.

Top concepts

MedicineCell BiologyCell DeathTumor BiologyCancer ResearchOncologyHematologyImmunologyPharmacologyCancer Biology

Publications per year

2021–2023

8

Publications

8

Mitochondrial regulation of GPX4 inhibition–mediated ferroptosis in acute myeloid leukemia

Hiroki Akiyama, Ran Zhao, Lauren B. Ostermann et al. · Leukemia · 2023 · 40 citations · Full text

Redox Signaling, Mitochondrial Function, Biochemistry +9

DNA-PK inhibitor peposertib enhances p53-dependent cytotoxicity of DNA double-strand break inducing therapy in acute leukemia

Eric Haines, Yuki Nishida, Michael I. Carr et al. · Scientific Reports · 2021 · 32 citations · Full text

Mixed-phenotype Acute Leukemia, Acute Leukemia Cells, Cell Death +19

AXL/MERTK inhibitor ONO-7475 potently synergizes with venetoclax and overcomes venetoclax resistance to kill <i>FLT3</i>-ITD acute myeloid leukemia

Sean M. Post, Huaxian Ma, Prerna Malaney et al. · Haematologica · 2021 · 31 citations · Full text

Axl/mertk Inhibitor Ono-7475, Immunology, Cell Death +19

Combined inhibition of BCL-2 and MCL-1 overcomes BAX deficiency-mediated resistance of TP53-mutant acute myeloid leukemia to individual BH3 mimetics

Bing Z. Carter, Po Yee Mak, Wenjing Tao et al. · Blood Cancer Journal · 2023 · 29 citations · Full text

Enhanced <i>TP53</i> reactivation disrupts <i>MYC</i> transcriptional program and overcomes venetoclax resistance in acute myeloid leukemias

Yuki Nishida, Jo Ishizawa, Edward Ayoub et al. · Science Advances · 2023 · 27 citations · Full text

Rows per page

1–5 of 8